Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $936M | $1.83B | $1.94B | $2.31B | $3.03B | $3.44B | $3.87B | $4.30B | $5.00B | $5.65B |
| Revenue growth | — | 95.4% | 6.1% | 19.1% | 31.3% | 13.4% | 12.5% | 11.2% | 16.2% | 13.0% |
| Gross profit | $262M | $446M | $422M | $513M | $682M | $780M | $867M | $981M | $1.01B | $1.09B |
| Gross margin | 28.0% | 24.4% | 21.8% | 22.2% | 22.5% | 22.7% | 22.4% | 22.8% | 20.3% | 19.3% |
| Operating income | -$11.0M | $27.3M | $38.3M | -$319K | $111M | $191M | $240M | $315M | $322M | $338M |
| Operating margin | -1.2% | 1.5% | 2.0% | -0.0% | 3.7% | 5.5% | 6.2% | 7.3% | 6.4% | 6.0% |
| Net income | -$42.8M | $3.88M | -$6.12M | -$75.9M | -$8.08M | $140M | $151M | $267M | $212M | $208M |
| Net margin | -4.6% | 0.2% | -0.3% | -3.3% | -0.3% | 4.1% | 3.9% | 6.2% | 4.2% | 3.7% |
| EPS (diluted) | -$0.55 | $0.03 | -$0.04 | -$0.49 | -$0.04 | $0.77 | $0.83 | $1.48 | $1.23 | $1.27 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$42.5M | $37.9M | $24.4M | $39.5M | $127M | $209M | $268M | $371M | $323M | $258M |
| Capital expenditures | — | $25.0M | $26.3M | $28.3M | $26.9M | $25.6M | $35.4M | $41.9M | $35.6M | $41.3M |
| Free cash flow | — | $12.9M | -$1.85M | $11.2M | $101M | $183M | $232M | $329M | $288M | $217M |
| Share buybacks | — | — | — | — | — | $0.00 | $0.00 | $250M | $253M | $310M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.57M | $39.5M | $36.4M | $67.1M | $99.3M | $119M | $294M | $344M | $413M | $233M |
| Total assets | $605M | $603M | $1.43B | $2.59B | $2.65B | $2.79B | $3.11B | $3.22B | $3.42B | $3.46B |
| Total liabilities | $567M | $606M | $825M | $1.68B | $1.63B | $1.62B | $1.73B | $1.80B | $2.02B | $2.13B |
| Long-term debt | $468M | $503M | $535M | $1.28B | $1.12B | $1.06B | $1.06B | $1.06B | $1.10B | $1.15B |
| Shareholders' equity | $601M | $606M | $603M | $907M | $1.02B | $1.18B | $1.39B | $1.42B | $1.40B | $1.33B |
| Retained earnings | -$645M | -$710M | -$16.0M | -$92.0M | -$100M | $39.9M | $190M | $458M | $669M | $877M |
| Shares (wtd avg diluted) | 118M | 128M | 143M | 156M | 181M | 181M | 182M | 180M | 173M | 163M |
Every figure is extracted from Option Care Health, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.